VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 4 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,881 | -49.0% | 73,352 | -22.2% | 0.01% | -47.8% |
| Q2 2023 | $621,332 | +86.4% | 94,284 | +92.0% | 0.02% | +64.3% |
| Q1 2023 | $333,389 | -11.1% | 49,100 | -3.3% | 0.01% | -30.0% |
| Q4 2022 | $375,139 | -25.6% | 50,763 | -0.5% | 0.02% | 0.0% |
| Q3 2022 | $504,000 | -14.6% | 51,000 | -5.7% | 0.02% | -20.0% |
| Q2 2022 | $590,000 | -25.4% | 54,100 | +7.4% | 0.02% | -50.0% |
| Q4 2021 | $791,000 | +107.6% | 50,387 | +98.8% | 0.05% | +38.9% |
| Q1 2021 | $381,000 | – | 25,342 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |